Pharmaceutical Contract Research Laboratory
This Contract Research Organisation (CRO) is located in Canada with GLP bioanalytical, in vitro/in vivo DM/PK and CMC analytical chemistry capabilities with very dependable staff and well-established history of global clientele including biotech and pharmaceutical companies. Client base steadily returns with new business, year after year. Future growth potential to be realized with strategic buyer.
A strategic buyer could benefit from expanding their own operations with a complete laboratory and animal testing facility, and outsource services to a broader user base. Or sell extended services to the loyal user base that is already established, and generating solid financial returns. In 2015, CRO industry revenue was estimated at $25.6 billion.
The business has a diverse range of experienced and long-term employees who will be a part of the transition to new owners. The current owner of the Pharmaceutical Contract Research Laboratory is willing to remain in the business after the sale for up to one (1) year to ensure a smooth transition.
Approximately 6,000 sq. ft. bioanalytical laboratory space and a 3,000 sq. ft. adjacent animal facility.
|2015||2016||2017||2018 (projected)||2019 (projected)|
|Net Income $||471,306||236,187||613,047||655,960||721,566|